IP Library Assignment 057094/0934
Patent Assignment
Reel/Frame 057094/0934

Assignment of Assignor's Interest

Recorded: 2021-08-05 Pages: 3
Assignor
GANYMED PHARMACEUTICALS GMBH
Executed: 2018-09-26
Assignee
ASTELLAS PHARMA INC.
5-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, 103-8411, JAPAN
Covered Property (1)
Therapy Involving Antibodies Against Claudin 18.2 for Treatment of Cancer
Application: 16/158,187 →
Publication: US 2019/0076525
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 12, 2018
From: UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ
To: TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBH
Reel/Frame 047149/0310 →
Assignment of Assignor's Interest Oct 12, 2018
From: TURECI, OZLEM
To: GANYMED PHARMACEUTICALS AG
Reel/Frame 047149/0324 →
Assignment of Assignor's Interest Oct 12, 2018
From: SAHIN, UGUR
To: GANYMED PHARMACEUTICALS AG; UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ
Reel/Frame 047149/0343 →
Change of Name Oct 12, 2018
From: GANYMED PHARMACEUTICALS AG
To: GANYMED PHARMACEUTICALS GMBH
Reel/Frame 047231/0164 →